Project Grant HT94252310288
Award Date
5/1/23
Completion Date
4/30/26
Dollars Obligated
$783K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
Rutgers The State University Of New Jersey, doing business as Rbhs-School Of Nursing, was awarded a $785,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund development of new therapeutic strategies for chemo brain in ovarian cancer survivors from July 1, 2023 through June 30, 2027. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $649,000 Project Grant to Rutgers, The State University of New Jersey to conduct research aimed at "Characterizing the Oncogenic Transcriptional Activation During the Malignant Transformation of NF1 Nerve Sheath Tumors." The 3-year award, which commenced on August 1, 2025, supports advanced biomedical research to transform healthcare for military service members, veterans, and the...
The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
The Defense Health Agency awarded a $250,000 Project Grant to Rutgers, The State University of New Jersey to conduct research titled "BOOSTING MYELINATION USING VISUAL FLICKER IN THE ACUTE CUPRIZONE INTOXICATION MODEL". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate medical solutions for the battlefield through basic, applied, and advanced biomedical research. The project is scheduled to be completed...
This federal Project Grant award of $785,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports mechanism-centric predictive modeling research for prostate cancer at Rutgers, The State University of New Jersey. The research aims to develop innovative approaches for improving diagnosis, treatment, and outcomes for military personnel and the public impacted by prostate cancer. Over the performance period from July 1, 2024...
The Defense Health Agency awarded a $863,500 Project Grant to Rutgers, The State University of New Jersey under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 1, 2022 will support research into "Genetically Distinct ASD Subtypes: Is MTOR Dysregulation a Common Mechanism?" Through this funding, Rutgers researchers will investigate potential connections between mutations in the MTOR gene pathway and autism...
The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $768,420.00 to Rutgers, The State University of New Jersey's Cancer Institute to conduct research on rewiring very long chain fatty acid metabolism in pancreatic tumor-associated macrophages. The goal is to overcome resistance to KRAS-targeted therapy in pancreatic cancer. The award period runs from July 1, 2025 to June 30, 2028. The research aims to...
The federal Block Grant award of $824,250 was provided by the Defense Health Agency to Rutgers, The State University of New Jersey, to support the Lung Cancer Research Program. This award, under the Military Medical Research and Development program (CFDA 12.420), will fund innovative biomedical research projects at Rutgers focused on improving health outcomes for military service members, veterans, and the broader public. Rutgers, leveraging its expertise in medicine, nursing, public health, and...